(Q35176725)

English

Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of ps

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of ps (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

1 reference

based on heuristic

inferred from title

behavior therapy

1 reference

based on heuristic

inferred from title

cognitive behavioral therapy

1 reference

based on heuristic

inferred from title

Joachim Klosterkötter

19

object named as

Joachim Klosterkötter

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

object named as

Martin Brüne

15

0 references

Hartmut Stützer

3

object named as

Hartmut Stützer

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Marion Lautenschlager

6

object named as

Marion Lautenschlager

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Walter de Millas

8

object named as

Walter de Millas

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

9

object named as

Birgit Janssen

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Tanja Maria Michel

11

object named as

Tanja Maria Michel

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Seza Krüger-Özgürdal

16

object named as

Seza Krüger-Özgürdal

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

17

object named as

Thomas Wobrock

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PREVENT study group

20

object named as

PREVENT study group

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

object named as

Wolfgang Maier

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4

object named as

Michael Wagner

0 references

7

object named as

Andreas Heinz

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Andreas Bechdolf

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Hendrik Müller

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Wolfgang Gaebel

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Frank Schneider

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Martin Lambert

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dieter Naber

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael Riedel

18

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Schizophrenia Bulletin

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

37 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

S111-21

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Early intervention for psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Research in people with psychosis risk syndrome: a review of the current evidence and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Prospective investigations of the prodromal state of schizophrenia: review of studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Aripiprazole for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Dopamine partial agonists: a new class of antipsychotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Early detection and intervention in the initial prodromal phase of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Diagnosing schizophrenia in the initial prodromal phase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Prediction of psychosis. A step towards indicated prevention of schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Public attitude towards psychiatric treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

13 July 2018

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental state

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Recent approaches to psychological interventions for people at risk of psychosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Axis-I disorders and vulnerability to psychosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

Lay recommendations on how to treat mental disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

27 September 2018

The burden of mental disorders in Victoria, 1996.

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBR083

21 January 2018

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBR083

21 January 2018

A cognitive model of the positive symptoms of psychosis

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBR083

21 January 2018

Canadian trends in mortality from mental disorders, 1965-1983.

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBR083

21 January 2018

Preventing progression to first-episode psychosis in early initial prodromal states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3160113

8 December 2018

Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21860040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive–behavioural therapy in first-episode and early schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21860040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21860040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/21860040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21860040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A heuristic vulnerability/stress model of schizophrenic episodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21860040

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/SCHBUL/SBR083

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35176725&oldid=2032473659"